首页> 外文OA文献 >Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

【2h】

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

机译：一线Cetuximab和Leucovorin，氟尿嘧啶和Oxaliplatin（Folfox-4）对RAS野生型转移性结肠直肠癌患者的疗效和耐受性，与Folfox-4相比：开放标签，随机，第III期裁缝试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Shukui Qin; Jin Li; Liwei Wang; Jianming Xu; Ying Cheng; Yuxian Bai; Wei Li; Nong Xu; Li-zhu Lin; Qiong Wu; Yunfeng Li; Jianwei Yang; Hongming Pan; Xuenong Ouyang; Wensheng Qiu; Kaichun Wu; Jianping Xiong; Guanghai Dai; Houjie Liang; Chunhong Hu; Jun Zhang; Min Tao; Qiang Yao; Junyuan Wang; Jiongjie Chen; S. Peter Eggleton; Tianshu Liu;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
2. Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial [J] . Qin Shukui, Li Jin, Wang Liwei, Journal of Clinical Oncology . 2018,第30期

机译：一线Cetuximab和Leucovorin，氟尿嘧啶和Oxaliplatin（Folfox-4）对RAS野生型转移性结肠直肠癌患者的疗效和耐受性，与Folfox-4相比：开放标签，随机，第III期裁缝试验
3. Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer [J] . Liangliang Bai, Pengfei Zhang, Kexun Zhou, Cancer Management and Research . 2019,第4期

机译：一线Cetuximab，氟尿嘧啶，氟尿嘧啶和Oxaliplatin（Folfox-4）对RAS野生型转移性结肠直肠癌患者的成本效果分析
4. Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients [J] . European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：用伊立替康/西替昔单抗的治疗序列，然后进行Folfox-4或转移性结肠直肠癌患者的反向策略，在第一线Folfiri / Bevacizumab后进展：用于研究胃肠癌期III的意大利组，随机试验比较两种治疗序列结肠直肠转移性患者
5. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
6. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
7. Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin Fluorouracil and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label Randomized Phase III TAILOR Trial [O] . Shukui Qin, Jin Li, Liwei Wang, -1

机译：一线西妥昔单抗联合白细胞素氟尿嘧啶和奥沙利铂（FOLFOX-4）与FOLFOX-4在RAS野生型转移性结直肠癌患者中的疗效和耐受性：开放标签随机III期TAILOR试验
8. >Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer [O] . Liangliang Bai, Pengfei Zhang, Kexun Zhou, 2019

机译：> RAS野生型转移性结肠直肠癌患者的一线甲嘧啶，氟尿嘧啶，氟尿嘧啶，氟哌林，氟尿嘧啶和oholfox-4）的成本效益分析

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

著录项

相似文献

相关主题

期刊订阅